Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

3.14
Delayed Data
As of Sep 04
 +0.04 / +1.29%
Today’s Change
2.50
Today|||52-Week Range
8.47
-34.03%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Computer Peripherals
MARKET CAP
$57.3M

Company Description

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops innovative adult stem cell therapeutic products. It currently focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in New York, NY.

Contact Information

Brainstorm Cell Therapeutics, Inc.
Three University Plaza Drive
Hackensack New Jersey 07601
P:(201) 488-0460
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Anthony S. FiorinoChief Executive Officer
Chaim LebovitsPresident
Uri YablonkaChief Operating Officer & Director
Yoram BibringChief Financial Officer & Treasurer
Yael GothelfVice President-Scientific & Regulatory Affairs